Skip to main content
Premium Trial:

Request an Annual Quote

EMBL European Bioinformatics Institute Awarded £45M from UK Government

NEW YORK (GenomeWeb) — The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) announced today that it has been awarded £45 million ($59.7 million) from the UK government to expand its computing infrastructure.

The EMBL-EBI develops freely available databases, tools, and software to enable the alignment, verification, and visualization of data produced in publicly funded research. It has been a contributor to the Human Cell Atlas and the UK Biobank, among other initiatives.

Cambridgeshire, England-based EMBL-EBI said it will use the funding — which is being made available through UK Research and Innovation's (UKRI) Strategic Priorities Fund — to increase its computing, storage, and building capacity.

"Our ability to process, access, and interrogate large volumes of data is absolutely crucial to scientific discovery in the 21st century, none more so than in health and life sciences where the fields of genomics and molecular biology are fuelling major advances," UKRI Chief Executive Mark Walport said in a statement. "This funding enables EMBL-EBI to continue to grow its global leadership in large biological datasets and bioinformatics, which are used by researchers all over the world, every day of the week."

The Scan

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.

Vitamin D From Tomatoes

According to Reuters, researchers in the UK have gene-edited tomatoes so their fruit contains vitamin D.

Cause Not Yet Spotted

NPR reports that a new study was unable to find a cause for persistent long COVID symptoms.

PNAS Papers on Central African Hunter-Gatherers, Myopia Development, Ancient Microtia Allele

In PNAS this week: population patterns among Central African hunter gatherers, effect of myopia-linked gene variant, and more.